Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site

Journal of Cell Science

Volumn 123, Issue 2, 2010, Pages 256-265

  Ulrichts, Peter ^a,b   Bovijn, Celia ^a,b   Lievens, Sam ^a,b   Beyaert, Rudi ^a,b   Tavernier, Jan ^a,b   Peelman, Frank ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Caspase 1; Mal; TIR domain; TLR

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MAL; TOLL INTERLEUKIN 1 RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS, ACIDIC; BINDING SITES; CASPASE 1; CELL LINE; CONSERVED SEQUENCE; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-1; SEQUENCE ALIGNMENT; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TWO-HYBRID SYSTEM TECHNIQUES;

MAMMALIA;

EID: 73849103316     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.056002     Document Type: Article

References (39)

1. Alexopoulou, L., Holt, A. C., Medzhitov, R. and Flavell, R. A. (2001). Recognition of double-stranded RNA and activation of NF-[kappa]B by Toll-like receptor 3. Nature 413, 732-738.
2. de Vries, S. J., van Dijk, A. D. and Bonvin, A. M. (2006). WHISCY: what information does surface conservation yield? Application to data-driven docking. Proteins 63, 479-489.
3. Eyckerman, S., Verhee, A., der Heyden, J. V., Lemmens, I., Ostade, X. V., Vandekerckhove, J. and Tavernier, J. (2001). Design and application of a cytokine-receptor-based interaction trap. Nat. Cell Biol. 3, 1114-1119.
4. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T. et al. (2001). Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83.
5. Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M. and Golenbock, D. T. (2003). LPS-TLR4 signaling to IRF-3/7 and NF-{kappa}B involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043-1055.
6. Gray, P., Dunne, A., Brikos, C., Jefferies, C. A., Doyle, S. L. and O'Neill, L. A. (2006). MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J. Biol. Chem. 281, 10489-10495.
7. Horng, T., Barton, G. M. and Medzhitov, R. (2001). TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835-841.
8. Horng, T., Barton, G. M., Flavell, R. A. and Medzhitov, R. (2002). The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420, 329-333.
9. Jiang, Z., Georgel, P., Li, C., Choe, J., Crozat, K., Rutschmann, S., Du, X., Bigby, T., Mudd, S., Sovath, S. et al. (2006). Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. PNAS 103, 10961-10966.
10. Kagan, J. C. and Medzhitov, R. (2006). Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955.
11. Kagan, J. C., Su, T., Horng, T., Chow, A., Akira, S. and Medzhitov, R. (2008). TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361-368.
12. Kawai, T. and Akira, S. (2006). TLR signaling. Cell Death. Differ. 13, 816-825.
13. Khan, J. A., Brint, E. K., O'Neill, L. A. and Tong, L. (2004). Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J. Biol. Chem. 279, 31664-31670.
14. Khor, C. C., Chapman, S. J., Vannberg, F. O., Dunne, A., Murphy, C., Ling, E. Y., Frodsham, A. J., Walley, A. J., Kyrieleis, O., Khan, A. et al. (2007). A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 39, 523-528.
15. Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Núñez, G., Janeway, C. A., Medzhitov, R. and Flavell, R. A. (2002). RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416, 194-199.
16. Lamkanfi, M., Kalai, M., Saelens, X., Declercq, W. and Vandenabeele, P. (2004). Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J. Biol. Chem. 279, 24785-24793.
17. Lang, T. and Mansell, A. (2007). The negative regulation of Toll-like receptor and associated pathways. Immunol. Cell Biol. 85, 425-434.
18. Lemmens, I., Eyckerman, S., Zabeau, L., Catteeuw, D., Vertenten, E., Verschueren, K., Huylebroeck, D., Vandekerckhove, J. and Tavernier, J. (2003). Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. Nucleic Acids Res. 31, e75.
19. Li, C., Zienkiewicz, J. and Hawiger, J. (2005). Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J. Biol. Chem. 280, 26152-26159.
20. Mansell, A., Brint, E., Gould, J. A., O'Neill, L. A. and Hertzog, P. J. (2004). Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4. J. Biol. Chem. 279, 37227-37230.
21. Miggin, S. M., Palsson-McDermott, E., Dunne, A., Jefferies, C., Pinteaux, E., Banahan, K., Murphy, C., Moynagh, P., Yamamoto, M., Akira, S. et al. (2007). NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc. Natl. Acad. Sci. USA 104, 3372-3377.
22. Nagpal, K., Plantinga, T. S., Wong, J., Monks, B. G., Gay, N. J., Netea, M. G., Fitzgerald, K. A. and Golenbock, D. T. (2009). A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J. Biol. Chem. 284, 25742-25748.
23. Núñez, M. R., Wong, J., Westoll, J. F., Brooks, H. J., O'Neill, L. A., Gay, N. J., Bryant, C. E. and Monie, T. P. (2007). A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS ONE. 2, e788.
24. Nyman, T., Stenmark, P., Flodin, S., Johansson, I., Hammarstrom, M. and Nordlund, P. (2008). The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J. Biol. Chem. 283, 11861-11865.
25. Ohnishi, H., Tochio, H., Kato, Z., Orii, K. E., Li, A., Kimura, T., Hiroaki, H., Kondo, N. and Shirakawa, M. (2009). Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc. Natl. Acad. Sci. USA 106, 10260-10265.
26. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. and Seya, T. (2003a). TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-[beta] induction. Nat. Immunol. 4, 161-167.
27. Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M. and Seya, T. (2003b). TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J. Biol. Chem. 278, 49751-49762.
28. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. and Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.
29. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C. et al. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
30. Rebsamen, M., Meylan, E., Curran, J. and Tschopp, J. (2008). The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death. Differ. 15, 1804-1811.
31. Ronni, T., Agarwal, V., Haykinson, M., Haberland, M. E., Cheng, G. and Smale, S. T. (2003). Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets. Mol. Cell. Biol. 23, 2543-2555.
32. Sarkar, A., Duncan, M., Hart, J., Hertlein, E., Guttridge, D. C. and Wewers, M. D. (2006). ASC directs NF-kappaB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J. Immunol. 176, 4979-4986.
33. Stennicke, H. R., Renatus, M., Meldal, M. and Salvesen, G. S. (2000). Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350, 563-568.
34. Ulrichts, P. and Tavernier, J. (2008). MAPPIT analysis of early Toll-like receptor signalling events. Immunol. Lett. 116, 141-148.
35. Ulrichts, P., Peelman, F., Beyaert, R. and Tavernier, J. (2007). MAPPIT analysis of TLR adaptor complexes. FEBS Lett. 581, 629-636.
36. Wesche, H., Henzel, W. J., Shillinglaw, W., Li, S. and Cao, Z. (1997). MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7, 837-847.
37. Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L. and Tong, L. (2000). Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408, 111-115.
38. Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T. et al. (2002). Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420, 324-329.
39. Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R. and Golenbock, D. (1999). Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1-5.